Cargando…

Evolution of Brain Volume Loss Rates in Early Stages of Multiple Sclerosis

OBJECTIVE: To describe the dynamics of brain volume loss (BVL) at different stages of relapsing-remitting multiple sclerosis (RRMS), to describe the association between BVL and clinical measures, and to investigate an effect of treatment escalation on the rate of BVL. METHODS: Together, 1903 patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Uher, Tomas, Krasensky, Jan, Malpas, Charles, Bergsland, Niels, Dwyer, Michael G., Kubala Havrdova, Eva, Vaneckova, Manuela, Horakova, Dana, Zivadinov, Robert, Kalincik, Tomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984675/ https://www.ncbi.nlm.nih.gov/pubmed/33727311 http://dx.doi.org/10.1212/NXI.0000000000000979

Ejemplares similares

Gray matter atrophy patterns in multiple sclerosis: A 10-year source-based morphometry study
por: Bergsland, Niels, et al.
Publicado: (2017)

Cognitive clinico‐radiological paradox in early stages of multiple sclerosis
por: Uher, Tomas, et al.
Publicado: (2017)

Natalizumab Induces Changes of Cerebrospinal Fluid Measures in Multiple Sclerosis
por: Ganapathy Subramanian, Ranjani, et al.
Publicado: (2021)

MRI correlates of disability progression in patients with CIS over 48 months
por: Uher, Tomas, et al.
Publicado: (2014)

Establishing pathological cut-offs for lateral ventricular volume expansion rates
por: Dwyer, Michael G., et al.
Publicado: (2018)

Volumetric MRI Markers and Predictors of Disease Activity in Early Multiple Sclerosis: A Longitudinal Cohort Study
por: Kalincik, Tomas, et al.
Publicado: (2012)

Bimonthly Evolution of Cortical Atrophy in Early Relapsing-Remitting Multiple Sclerosis over 2 Years: A Longitudinal Study
por: Zivadinov, Robert, et al.
Publicado: (2013)

Monitoring of radiologic disease activity by serum neurofilaments in MS
por: Uher, Tomas, et al.
Publicado: (2020)

Additive Effect of Spinal Cord Volume, Diffuse and Focal Cord Pathology on Disability in Multiple Sclerosis
por: Andelova, Michaela, et al.
Publicado: (2019)

Neurological software tool for reliable atrophy measurement (NeuroSTREAM) of the lateral ventricles on clinical-quality T2-FLAIR MRI scans in multiple sclerosis
por: Dwyer, Michael G., et al.
Publicado: (2017)

Isolated Cognitive Decline in Neurologically Stable Patients with Multiple Sclerosis
por: Motyl, Jiri, et al.
Publicado: (2021)

Periventricular gradient of T(1) tissue alterations in multiple sclerosis
por: Vaneckova, Manuela, et al.
Publicado: (2022)

Environmental Factors Associated with Disease Progression after the First Demyelinating Event: Results from the Multi-Center SET Study
por: Horakova, Dana, et al.
Publicado: (2013)

Brainstem lesions are associated with diffuse spinal cord involvement in early multiple sclerosis
por: Andelova, Michaela, et al.
Publicado: (2022)

Oxidative Stress Markers in Cerebrospinal Fluid of Newly Diagnosed Multiple Sclerosis Patients and Their Link to Iron Deposition and Atrophy
por: Burgetova, Andrea, et al.
Publicado: (2022)

Diagnostic delay of multiple sclerosis: prevalence, determinants and consequences
por: Uher, Tomas, et al.
Publicado: (2023)

Multiple Sclerosis Relapses Following Cessation of Fingolimod
por: Malpas, Charles B., et al.
Publicado: (2022)

Validating atlas-based lesion disconnectomics in multiple sclerosis: A retrospective multi-centric study
por: Ravano, Veronica, et al.
Publicado: (2021)

Reliable measurements of brain atrophy in individual patients with multiple sclerosis
por: Smeets, Dirk, et al.
Publicado: (2016)

Deep Gray Matter Iron Content in Neuromyelitis Optica and Multiple Sclerosis
por: Pudlac, Adam, et al.
Publicado: (2020)

Clinical correlates of grey matter pathology in multiple sclerosis
por: Horakova, Dana, et al.
Publicado: (2012)

Peripheral blood lymphocytes immunophenotyping predicts disease activity in clinically isolated syndrome patients
por: Posová, Helena, et al.
Publicado: (2017)

CSF Markers of Oxidative Stress Are Associated with Brain Atrophy and Iron Accumulation in a 2-Year Longitudinal Cohort of Early MS
por: Burgetova, Andrea, et al.
Publicado: (2023)

Neuroimaging Correlates of Patient-Reported Outcomes in Multiple Sclerosis
por: Jakimovski, Dejan, et al.
Publicado: (2023)

Measuring Aqueduct of Sylvius Cerebrospinal Fluid Flow in Multiple Sclerosis Using Different Software
por: Laganà, Maria Marcella, et al.
Publicado: (2021)

Retinal Blood Vessel Analysis Using Optical Coherence Tomography (OCT) in Multiple Sclerosis
por: Young, Nicholas, et al.
Publicado: (2023)

Longitudinal analysis of cerebral aqueduct flow measures: multiple sclerosis flow changes driven by brain atrophy
por: Jakimovski, Dejan, et al.
Publicado: (2020)

Understanding the positive benefit:risk profile of alemtuzumab in relapsing multiple sclerosis: perspectives from the Alemtuzumab Clinical Development Program
por: Havrdova, Eva, et al.
Publicado: (2017)

Decreasing brain iron in multiple sclerosis: The difference between concentration and content in iron MRI
por: Schweser, Ferdinand, et al.
Publicado: (2020)

Serum Neurofilament Light Chain Levels are Associated with Lower Thalamic Perfusion in Multiple Sclerosis
por: Jakimovski, Dejan, et al.
Publicado: (2020)

Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement
por: Reyes, Saúl, et al.
Publicado: (2021)

Iron-related gene variants and brain iron in multiple sclerosis and healthy individuals
por: Hagemeier, Jesper, et al.
Publicado: (2017)

Real-Life Outcome in Multiple Sclerosis in the Czech Republic
por: Kobelt, Gisela, et al.
Publicado: (2019)

Lexical and syntactic deficits analyzed via automated natural language processing: the new monitoring tool in multiple sclerosis
por: Šubert, Martin, et al.
Publicado: (2023)

Corrigendum to ’To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection’[Multiple sclerosis and related disorders vol. 65 (2022) 104014]
por: Stastna, Dominika, et al.
Publicado: (2023)

Validation of the Czech Version of the Dysphagia in Multiple Sclerosis Questionnaire (DYMUS)
por: Novotná, Klára, et al.
Publicado: (2022)

Factors influencing daily treatment choices in multiple sclerosis: practice guidelines, biomarkers and burden of disease
por: Berger, Thomas, et al.
Publicado: (2020)

Brain atrophy and lesion burden are associated with disability progression in a multiple sclerosis real-world dataset using only T2-FLAIR: The NeuroSTREAM MSBase study
por: Barnett, Michael, et al.
Publicado: (2021)

The potential of serum neurofilament as biomarker for multiple sclerosis
por: Bittner, Stefan, et al.
Publicado: (2021)

Improved assessment of multiple sclerosis lesion segmentation agreement via detection and outline error estimates
por: Wack, David S, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_blc3eoco66i9nmvulv2011nd11